This article is more than 5 years old. Information may no longer be current.
CreakyJoints asks insurance companies to disclose any potential cost-savings for arthritis drugs
Click Here to Manage Email Alerts
The arthritis patient-advocacy group CreakyJoints has asked insurance companies to disclose any potential cost-savings if a medication could be purchased at a cheaper price by mail or from an alternative pharmacy and to pass along the savings if there is a re-negotiation that results in a lower drug price.
“Patient communities rarely have a complete understanding of how much their medication costs because they are not at the negotiation table with the enormously profitable companies who set prices,” Louis Tharp, executive director and co-founder of CreakyJoints and the Global Healthy Living Foundation, said in a press release. “Our goal is to raise the veil on how drug prices are set because insurance companies play a larger role than the average person realizes.”
CreakyJoints also advocated for the following items in its new policy platform:
- quicker approval of generics by the FDA, as more than 4,000 currently await review;
- more prescription medications allowed by the FDA to be sold over the counter;
- coverage of these drugs by insurance companies;
- health savings accounts for over the counter drugs; and
- notification by a pharmacy if a drug would cost less without insurance.
“Further, we plan to advocate for health policies and laws that put people ahead of profits while strongly encouraging continued research and innovation because increased treatment options will benefit the patient community while stimulating the economy,” Tharp said.
For more information visit: https://creakyjoints.org/4ways/
Reference: